China’s State FDA Lays Out Plans To Spur Innovation – DIA China Conference
This article was originally published in PharmAsia News
Executive Summary
SFDA Commissioner Yin Li lays out innovation, drug safety plans to achieve China’s 12th Five-Year Plans.